A real-world survival of subsequent therapy in ALK positive non-small cell lung cancer (NSCLC) patients with crizotinib resistance.

Lu Yang,Di Ma,Fei Xu,Haiyan Xu,Li Junling,P. Xing,Xuezhi Hao,Yan Wang

A real-world survival of subsequent therapy in ALK positive non-small cell lung cancer (NSCLC) patients with crizotinib resistance.

2018

Lu Yang
Di Ma
Fei Xu
Haiyan Xu
Li Junling
P. Xing
Xuezhi Hao
Yan Wang

e21093Background: Crizotinib resistance among non-small cell lung cancer(NSCLC) patients with ALK gene rearrangement has attracted more attention. Subsequent therapies beyond crizotinib resistance ...

Keywords:

non-small cell lung cancer (NSCLC)
ALK-Positive
Pathology
Oncology
Crizotinib
Medicine
Internal medicine
non small cell
ALK Gene Rearrangement
Cancer research
crizotinib resistance

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations